Attached files
| file | filename |
|---|---|
| EX-21.1 - EX-21.1 - Global Blood Therapeutics, Inc. | d121613dex211.htm |
| S-1 - S-1 - Global Blood Therapeutics, Inc. | d121613ds1.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Global Blood Therapeutics, Inc.:
We consent to the use of our report incorporated by reference herein and to the reference to our firm under the heading “Experts” in the prospectus.
(signed) KPMG LLP
San Francisco, California
June 10, 2016